A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele
- PMID: 12244107
- DOI: 10.1074/jbc.M206894200
A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele
Abstract
A common T17A polymorphism in the signal peptide of the cytotoxic T-lymphocyte antigen 4 (CTLA-4), a T-cell receptor that negatively regulates immune responses, is associated with risk for autoimmune disease. Because the polymorphism is absent from the mature protein, we hypothesized that its biological effect must involve early stages of protein processing, prior to signal peptide cleavage. Constructs representing the two alleles were compared by in vitro translation, in the presence of endoplasmic reticulum membranes. We studied glycosylation by endoglycosidase H digestion and glycosylation mutant constructs, cleavage of peptide with inhibitors, and membrane integration by ultracentrifugation and proteinase K sensitivity. A major cleaved and glycosylated product was seen for both alleles of the protein but a band representing incomplete glycosylation was markedly more abundant in the predisposing Ala allele (32.7 +/- 1.0 versus 10.6% +/- 1.2 for Thr, p < 10(-9)). In addition, differential intracellular/surface partitioning was studied with co-transfection of the alleles fused to distinct fluorescent proteins in COS-1 cells. By quantitative confocal microscopy we found a higher ratio of cell surface/total CTLAThr(17) versus CTLAAla(17) (p = 0.01). Our findings corroborate observations, in other proteins, that the signal peptide can determine the efficiency of post-translational modifications other than cleavage and suggest inefficient processing of the autoimmunity predisposing Ala allele as the explanation for the genetic effect.
Similar articles
-
Markers for risk of type 1 diabetes in relatives of Alsacian patients with type 1 diabetes.Int J Exp Diabetes Res. 2002;3(1):1-9. doi: 10.1080/15604280212527. Int J Exp Diabetes Res. 2002. PMID: 11900275 Free PMC article.
-
Cloning and sequencing of dog cDNA encoding the T-cell costimulatory molecule (CTLA-4).Immunogenetics. 2000 Jan;51(1):79-81. doi: 10.1007/s002510050013. Immunogenetics. 2000. PMID: 10663567 No abstract available.
-
CTLA-4 and autoimmune thyroid disease: lack of influence of the A49G signal peptide polymorphism on functional recombinant human CTLA-4.Cell Immunol. 2002 Feb;215(2):133-40. doi: 10.1016/s0008-8749(02)00018-7. Cell Immunol. 2002. PMID: 12202150
-
CTLA-4, a negative regulator of T-lymphocyte activation.Immunol Rev. 1996 Oct;153:183-207. doi: 10.1111/j.1600-065x.1996.tb00925.x. Immunol Rev. 1996. PMID: 9010724 Review. No abstract available.
-
CTLA-4 and T cell activation.Curr Opin Immunol. 1999 Jun;11(3):294-300. doi: 10.1016/s0952-7915(99)80047-8. Curr Opin Immunol. 1999. PMID: 10375557 Review.
Cited by
-
CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.Endocrine. 2017 Jan;55(1):186-199. doi: 10.1007/s12020-016-1096-1. Epub 2016 Sep 16. Endocrine. 2017. PMID: 27638540 Free PMC article.
-
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.Immunity. 2016 May 17;44(5):955-72. doi: 10.1016/j.immuni.2016.05.002. Immunity. 2016. PMID: 27192563 Free PMC article. Review.
-
Association of CT60 cytotoxic T lymphocyte antigen-4 gene polymorphism with thyroid autoantibody production in patients with Hashimoto's and postpartum thyroiditis.Clin Exp Immunol. 2010 Jul 1;161(1):41-7. doi: 10.1111/j.1365-2249.2010.04113.x. Epub 2010 Apr 9. Clin Exp Immunol. 2010. PMID: 20408864 Free PMC article.
-
The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease.Immunology. 2009 Sep;128(1 Suppl):e787-96. doi: 10.1111/j.1365-2567.2009.03083.x. Epub 2009 Feb 17. Immunology. 2009. PMID: 19740340 Free PMC article.
-
Genetic overlap between type 1 diabetes and other autoimmune diseases.Semin Immunopathol. 2022 Jan;44(1):81-97. doi: 10.1007/s00281-021-00885-6. Epub 2021 Oct 1. Semin Immunopathol. 2022. PMID: 34595540 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases